These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 24749492)
1. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis. Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492 [TBL] [Abstract][Full Text] [Related]
2. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity. Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433 [TBL] [Abstract][Full Text] [Related]
3. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. Liu C; Li Y; Yu J; Feng L; Hou S; Liu Y; Guo M; Xie Y; Meng J; Zhang H; Xiao B; Ma C PLoS One; 2013; 8(2):e54841. PubMed ID: 23418431 [TBL] [Abstract][Full Text] [Related]
4. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis. Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors. Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431 [TBL] [Abstract][Full Text] [Related]
7. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes. Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673 [TBL] [Abstract][Full Text] [Related]
8. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis. Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128 [TBL] [Abstract][Full Text] [Related]
9. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142 [TBL] [Abstract][Full Text] [Related]
10. Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. Chen C; Yu JZ; Zhang Q; Zhao YF; Liu CY; Li YH; Yang WF; Ma CG; Xiao BG Neuromolecular Med; 2015 Dec; 17(4):454-65. PubMed ID: 26481340 [TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis. Zhao YF; Zhang X; Ding ZB; Yang XW; Zhang H; Yu JZ; Li YH; Liu CY; Zhang Q; Zhang HZ; Ma CG; Xiao BG J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms. Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558 [TBL] [Abstract][Full Text] [Related]
13. Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil. Yu JZ; Chen C; Zhang Q; Zhao YF; Feng L; Zhang HF; Meng J; Ma CG; Xiao BG Wound Repair Regen; 2016 Mar; 24(2):317-27. PubMed ID: 26789651 [TBL] [Abstract][Full Text] [Related]
14. Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis. Guo SD; Liu CY; Yu JW; Chai Z; Wang Q; Mi XT; Song GB; Li YH; Yang PW; Feng L; Xiao BG; Ma CG CNS Neurosci Ther; 2019 Jun; 25(6):783-795. PubMed ID: 30779332 [TBL] [Abstract][Full Text] [Related]
15. FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms. Li YH; Xie C; Zhang Y; Li X; Zhang HF; Wang Q; Chai Z; Xiao BG; Thome R; Zhang GX; Ma CG Sci Rep; 2017 Jan; 7():41227. PubMed ID: 28112256 [TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis. González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model. He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388 [TBL] [Abstract][Full Text] [Related]
18. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase. Hao W; Luo Q; Menger MD; Fassbender K; Liu Y Front Immunol; 2021; 12():792465. PubMed ID: 34975892 [TBL] [Abstract][Full Text] [Related]
19. FSD-C10 Shows Therapeutic Effects in Suppressing oxidized low-density lipoprotein (ox-LDL)-Induced Human Brain Microvascular Endothelial Cells Apoptosis via Rho-Associated Coiled-Coil Kinase (ROCK)/Mitogen-Activated Protein Kinase (MAPK) Signaling. Wang X; Mao R; Chen W Med Sci Monit; 2018 Aug; 24():5509-5516. PubMed ID: 30088495 [TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]